Pacira Biosciences Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. My name is Balaji Prasad. I lead the Specialty Pharmaceuticals coverage for Barclays. Continuing on day 2 of our spec pharma track, I'm delighted to have the management team of Pacira with us. So from Pacira, we have Dave Stack, Chairman and CEO; and Charles Reinhart, CFO.
Dave and Charlie, thank you for taking your time and joining us today.
Thank you for the opportunity.
Questions & Answers
Fantastic. So I think as we look now with the updates that you had recently, and you also provided the Feb monthly sales. The question that I have been getting in the past few weeks since the Q4 call is really about ZILRETTA. I think there still seems to be significant confusion over the manufacturing issues on the contract rates that you had and what it means for your 2020 outlook with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |